The following is a summary of “Single cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis ...

Read on for tips, suggestions and insight from Dr. Anna Chacon, MD, board-certified dermatologist and writer at My Psoriasis ...

Piclidenoson, an orally administered drug, has demonstrated a safety and efficacy profile in a Phase III trial for psoriasis ...

Few treatments have revolutionised care for people with chronic inflammatory disorders more than biologic and small molecule ...

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.

Data Reported by Can-Fite Veterinary Partner Vetbiolix who already exercised its option for a full license deal worth $325M ...

Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get ...

Taiwan’s REGiMMUNE and Europe-based Kiji Therapeutics are merging to create a globally minded regulatory T-cell biotech that ...

Johnson amp Johnson JampJ raised its 2024 profit and sales forecasts on October 15 thanks to strong sales of oncology drugs ...

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two ...